Both higher BDNF methylation (23, 54) and lower BDNF protein levels (55–60) are associated with worse neurobehavioral outcomes in children with preterm birth, attention-deficit/hyperactivity disorder (ADHD), bipolar disorder, anorexia, and autism spectrum disorder. This evidence concerns the gene BDNF and autism spectrum disorder.